Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Is there to be a direct head to head trial in any of the forthcoming trials for AvA6000?
I’m under the impression time on drug and progression free survival are more than adequate. There’s 50 years of records of dox available. Ava6000 has a low bar to success as it only has to be as good as dox in efficacy, as side effects are already greatly reduced.
If you want to go down that route it’s more likely Fiona was given the boot not being an oncologist when and oncologists Christina walked in the room. A plausible deramp but Christina is qualified in the clinic Fiona isn’t, so any pivot would have probably happened when Fiona fu cked up not the other way round. Personally feel this is just as you said conspiracy clap trap.
I’m up for hearing what they have to say, hurrying into sacking the CEO after so many years might be rash, personally I’m 50% down. But that shouldn’t affect the rationale of how to get out of this situation. Folk that think parachuting so and so out of of this, should be careful of what they wish for. Cool heads dudes
No Derek, the release of the data at a highly regarded conference where all the industry are, is way more impactful. You could make an argument that the raise had to come so there’s money in the bank when the data is presented
Scuttling around on Twitter following anyone that follows these retail heavy stocks then pumping out drivel with a dose of told you so. Which he was undoubtedly told by some spiv a few days ago. Little smarmy low life grease ball, wannabe fin twist guru. C un t more like